Health Technology Assessment

Medlior's team of experienced consultants, industry advisors, and health economists are able to help prepare drug reimbursement submission dossiers for Canadian and international HTA agencies. Our team is experienced in preparing submission dossiers for the Canadian Agency for Drugs and Technologies in Health (CADTH) Common Drug Review (CDR) and pan-Canadian Oncology Drug Review (pCODR).

We offer the following HTA services:

  • Preparation of the clinical component, including the:
    • Executive Summary,
    • Clinical Summary (including disease overview, current treatment landscape, clinical efficacy, and safety),
    • Documentation supporting the Clinical Summary of the CDR submission
  • Preparation of the economic component, including:
    • Adaptation or preparation of Cost-Effectiveness analysis,
    • Report (aligned with the 2017 CADTH guidelines)
  • Response to the CADTH Reviewers' Report
  • Adapting CDR reports for submission to INESSS

Canadian HTA

International HTA